Showing results (1571-1580 of 9,979) with videos related to

Sort By:
Pageof 998
Leukemia & Lymphoma|November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulinJeremy T Larsen, William J Hogan, Ivana N Micallef, et al.
Leukemia & Lymphoma|May 24, 2012
Off-target effects of BCR-ABL1 inhibitors and their potential long-term implications in patients with chronic myeloid leukemiaJuan Luis Steegmann, Francisco Cervantes, Philipp le Coutre, et al.
Leukemia & Lymphoma|May 24, 2012
Targeting the B cell receptor pathway in chronic lymphocytic leukemiaMatthew S Davids, Jennifer R Brown
Leukemia & Lymphoma|May 24, 2012
Chronic myeloid leukemia stem cells display alterations in expression of genes involved in oxidative phosphorylationKrzysztof Flis, David Irvine, Mhairi Copland, et al.
Leukemia & Lymphoma|December 6, 2013
Association of XRCC3 Thr241Met polymorphism and leukemia risk: evidence from a meta-analysisYulan Yan, Hongjie Liang, Taijie Li, et al.
Leukemia & Lymphoma|December 7, 2013
Bendamustine and melphalan kill myeloma cells similarly through reactive oxygen species production and activation of the p53 pathway and do not overcome resistance to each otherSylvanie Surget, Emilie Lemieux-Blanchard, Sophie Maïga, et al.
Leukemia & Lymphoma|November 12, 2013
Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignanciesTariq I Mughal, Saulius Girnius, Steven T Rosen, et al.
Leukemia & Lymphoma|November 12, 2013
CAMKIIγ, HSP70 and HSP90 transcripts are differentially expressed in chronic myeloid leukemia cells from patients with resistant mutated diseaseMariana Gonzalez, Carlos De Brasi, Cristian Ferri, et al.
Leukemia & Lymphoma|November 29, 2013
Increased expression of costimulatory molecules CD86 and sCTLA-4 in patients with acute lymphoblastic leukemiaAmany Mansour, Tawfik Elkhodary, Ahmad Darwish, et al.
Leukemia & Lymphoma|December 3, 2013
Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphomaStefania Nobili, Cristina Napoli, Benedetta Puccini, et al.
Pageof 998